Abvc Biopharma ABVC
NASDAQ ABVC
$0.88 -0.02 (-2.20%)
As of: Aug 21, 2026 · 2:24 PM EDT

Abvc Biopharma (ABVC) EBT Margin (QoQ) (2010 - 2025)

Abvc Biopharma (ABVC) EBT Margin (QoQ) (2010 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.89 Bn 131.04 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 86.05 Bn 78.06 Bn 3.93 Bn
3 Argenx Se 65.56 Bn 60.38 Bn 1.37 Bn
4 Moderna 55.46 Bn 50.32 Bn 52.00 Mn
5 BeOne Medicines 42.12 Bn 37.02 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.62 Bn 28.31 Bn 992.69 Mn
7 BioNTech SE 27.70 Bn 9.30 Bn 668.28 Mn
8 Insmed 27.51 Bn 26.35 Bn 358.27 Mn
9 Royalty Pharma 27.38 Bn 26.54 Bn -
10 Abvc Biopharma 23.19 Mn 23.19 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 65,643.00
Dec 31, 2024 -4.04 Mn
Sep 30, 2024 86,368.00
Jun 30, 2024 24.20 Mn
Mar 31, 2024 -21.87 Mn
Dec 31, 2023 -303,886.00
Sep 30, 2023 1.54 Mn
Jun 30, 2023 -3.51 Mn
Mar 31, 2023 -87,838.00
Dec 31, 2022 832,382.00
Sep 30, 2022 -827,573.00
Jun 30, 2022 2.34 Mn
Mar 31, 2022 -2.56 Mn
Dec 31, 2021 347,824.00
Sep 30, 2021 473,725.00
Jun 30, 2021 -624,537.00
Mar 31, 2021 765,516.00
Dec 31, 2020 -624,579.00
Sep 30, 2020 -89,732.00
Jun 30, 2020 59,777.00